Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
2.395 USD | +3.23% | -9.43% | +41.18% |
Apr. 23 | Capital One Starts Heron Therapeutics With Overweight Rating, $6 Price Target | MT |
Mar. 21 | Heron Therapeutics, Inc. Announces Executive Changes, Effective March 29, 2024 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+41.18% | 349M | |
+0.28% | 42.19B | |
+44.30% | 40.15B | |
-6.20% | 28.31B | |
+5.88% | 24.63B | |
-24.41% | 18.2B | |
+26.81% | 12.01B | |
-3.17% | 11.76B | |
+10.51% | 10.4B | |
-1.33% | 9.94B |
- Stock Market
- Equities
- HRTX Stock
- News Heron Therapeutics, Inc.
- Needham & Co Adjusts Heron Therapeutics Price Target to $16 From $24, Maintains Buy Rating